22.2 C
New York
Monday, May 12, 2025
HomeEntertainmentEU seeks feedback on Microsoft's Activision remedies for UK watchdog | Reuters...

EU seeks feedback on Microsoft’s Activision remedies for UK watchdog | Reuters News Agency

Date:

Related stories

Free Online Bonus Game Slots

Free Online Bonus Game Slots We were pretty impressed...

Free Online Bonus Game Slots

Free Online Bonus Game Slots We were pretty impressed...

Jackpot Party Casino No Deposit Bonus 100 Free Spins

Jackpot Party Casino No Deposit Bonus 100 Free Spins...

Jackpot Party Casino No Deposit Bonus 100 Free Spins

Jackpot Party Casino No Deposit Bonus 100 Free Spins...

Win Real Money Slots Online Ireland

Win Real Money Slots Online Ireland Win real money...

Business & FinanceEntertainment & LifestyleTechnology

Reuters exclusively reported that EU antitrust regulators are asking Microsoft’s (MSFT.O) rivals and customers whether they are affected by the U.S. tech giant’s proposals to gain UK approval for its $69 billion acquisition of Activision Blizzard (ATVI.O). The European Commission had cleared the deal in May after Microsoft agreed to license popular Activision games such as “Call of Duty” to rival game-streaming platforms.That clearance was given before Microsoft proposed the Ubisoft deal to appease the UK regulator. 

Market Impact

Microsoft last month offered to sell its cloud streaming rights to Ubisoft Entertainment (UBIP.PA) after Britain’s Competition and Markets Authority (CMA) blocked the biggest gaming deal in history 

Article Tags

Topics of Interest: Business & FinanceEntertainment & LifestyleTechnology

Type: Reuters Best

Sectors: Business & FinanceRetail & Consumer GoodsTechnology

Regions: Europe

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Important Regional Story

Source link

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

LEAVE A REPLY

Please enter your comment!
Please enter your name here